Last checked at 14 Sep 2017 10:09
Scrip Dividend - calculation price
Reading, United Kingdom (14 September 2017)
On 3 August 2017 ConvaTec Group Plc ("ConvaTec" or "the Company") declared an interim dividend of 1.4 cents per share (the "interim dividend"). This interim dividend is to be paid on 20 October 2017 to shareholders on the share register as at 8 September 2017 ("record date"). The dividend is payable in cash in sterling to holders of ordinary shares. On 11 September 2017 the Company announced that a scrip dividend scheme will be made available for this interim dividend allowing shareholders to elect to receive their dividend in the form of new ordinary shares.
The "Calculation Price" for the issue of new ordinary shares under the scrip dividend scheme is:
272 pence for each new ordinary share
This is equivalent to 1 new share for approximately 256.6 shares held prior to the ex-dividend date of 7 September 2017
The Calculation Price is the average of the middle market quotations of a ConvaTec share, derived from the London Stock Exchange Daily Official List, for the five consecutive business days from 7 September to 13 September 2017 (inclusive).
The latest date for receipt of elections to participate in the scrip dividend scheme for this interim dividend is 29 September 2017. Shareholders must return their mandate form by 5pm (GMT) or otherwise input their CREST elections to be received by the Company's registrar, Computershare, by 3pm (GMT) on 29 September 2017. Elections received after this deadline will apply to subsequent dividends only. Unless revoked by you, your scrip dividend election will apply for all future dividends for which a scrip dividend is offered. Evergreen elections for CREST shareholders cannot be accepted and elections will revert to cash by default after the payment of each dividend.
Details of the scrip dividend scheme are available at www.convatecgroup.com/investors
TIMETABLE
Key dates in respect of the scrip dividend scheme for the interim dividend are:
Ex-dividend Date | 7 September 2017 |
Record Date | 8 September 2017 |
Scrip calculation price determined | 7-13 September 2017 (inclusive) |
Scrip calculation price available and announced | 14 September 2017 |
Mandate delivery deadline for Shares held in uncertificated form | 3.00 p.m. on 29 September 2017 |
Mandate delivery deadline for Shares held in certificated form | 5.00 p.m. on 29 September 2017 |
Announcement of the total amount of new shares to be issued | 5 October 2017 |
Dividend payment date | 20 October 2017 |
Dispatch of statement in accordance with section 7 of Scheme Rules and share certificates, CREST accounts credited/updated, and first day of dealings in New Shares | 20 October 2017 |
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Alastair Elwen, Finsbury +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435
Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582
investorrelations@convatec.com
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
# # #